日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dapagliflozin, in addition to ramipril, ameliorates kidney disease progression in mice with Alport syndrome.

达格列净与雷米普利联合使用,可改善患有阿尔波特综合征的小鼠的肾脏疾病进展

Miyata Kana N, Smith Denise M, Yamashita Michifumi, Kim Shimok, Yeargin F Andrea, Beganovic Melisa, Zhang Shao-Ling, Chan John S D, Miner Jeffrey H, Leal Daniel N, Li Jian-Ping, Bruno Jonathan